|
Market Closed -
Nasdaq
23:00:00 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 148.09 USD | -0.46% |
|
+0.33% | +20.65% |
| 08-25 | Wall Street Wants Receipts |  |
| 08-25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.46% | +0.33% | +14.52% | +10.74% | +20.65% | +29.05% | +92.67% | +107.32% | +85.65% | 184B | |
| -3.59% | -7.10% | -0.55% | +11.71% | +10.68% | +61.60% | +114.83% | +355.15% | +1,420.21% | 1,100B | |
| -1.15% | -1.25% | +2.51% | +17.30% | +30.47% | +52.98% | +62.41% | +55.80% | +126.81% | 658B | |
| -1.09% | -1.15% | +1.36% | +23.36% | +15.06% | +26.18% | +79.22% | +118.36% | +306.90% | 470B | |
| -1.47% | +0.24% | +3.72% | +11.20% | +12.22% | +42.09% | +42.09% | +0.70% | +52.89% | 372B | |
| -0.90% | +0.05% | +0.22% | +7.38% | +16.04% | +25.57% | +41.75% | +50.97% | +64.32% | 304B | |
| -1.94% | +1.53% | -5.07% | -12.36% | -11.28% | +3.05% | +13.24% | +42.59% | +146.90% | 264B | |
| -0.43% | -0.46% | +17.10% | +31.08% | +34.53% | +52.06% | +71.75% | +98.83% | +156.06% | 239B | |
| -0.93% | +1.84% | -4.88% | +6.11% | -6.24% | -13.11% | -52.28% | -7.25% | +96.24% | 213B | |
| -0.95% | +0.21% | +15.32% | +9.48% | +13.65% | +13.56% | -22.21% | -40.27% | -18.72% | 163B | |
| -1.01% | -0.86% | +14.65% | +25.55% | +20.72% | +41.35% | +56.34% | +176.06% | +463.69% | 140B | |
| -0.52% | -0.06% | +8.83% | +16.44% | +25.27% | +43.13% | +8.84% | +0.87% | +14.97% | 139B | |
| -0.57% | -0.34% | +2.97% | +2.58% | -5.36% | -9.26% | -20.69% | -11.49% | +12.89% | 110B | |
| -0.31% | -0.86% | -3.14% | -1.32% | +4.11% | +29.26% | +35.89% | +2.77% | -7.88% | 104B | |
| -1.38% | +1.19% | +1.74% | -8.16% | -15.48% | +15.90% | +57.87% | +62.59% | +546.09% | 71.79B | |
| -0.78% | +0.80% | +0.80% | +14.92% | +20.27% | +32.10% | +30.03% | +58.66% | +29.54% | 58.27B | |
| -0.30% | +0.20% | +6.62% | +29.85% | +32.69% | +71.77% | -1.88% | +3.74% | -49.37% | 56.48B | |
| -0.58% | -11.23% | -13.02% | -5.95% | -21.96% | -29.84% | +14.17% | -1.94% | +183.98% | 45.53B | |
| +1.00% | +4.30% | +0.84% | +9.18% | -0.40% | +4.33% | +14.30% | - | - | 44.39B | |
| -0.47% | +1.20% | +23.08% | +9.56% | +21.50% | +108.93% | +290.93% | +307.74% | -26.44% | 44.4B | |
| Average | -0.88% | +0.23% | +4.38% | +10.43% | +10.86% | +30.04% | +46.46% | +72.69% | +189.72% | 238.98B | |
| Weighted average by Cap. | -1.58% | -1.13% | +2.99% | +12.38% | +13.89% | +37.85% | +59.94% | +124.74% | +433.09% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
